Costs and financial feasibility of malaria elimination

Lancet. 2010 Nov 6;376(9752):1604-15. doi: 10.1016/S0140-6736(10)61355-4. Epub 2010 Oct 28.

Abstract

The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework-potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • China / epidemiology
  • Cost Savings
  • Cost-Benefit Analysis
  • Demography
  • Eswatini / epidemiology
  • Health Expenditures
  • Humans
  • Malaria / economics*
  • Malaria / epidemiology
  • Malaria / prevention & control*
  • Mauritius / epidemiology
  • Tanzania / epidemiology